← Leaderboards
David J Austin
University Of Texas Md Anderson Can Ctr
$1,230,858
Attributed
$1,230,858
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,230,858 · 3
By mechanism
R01$693,131 · 1
R21$458,404 · 1
P01$79,323 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Macus T Kuo$7,802,009
- Richard E. Champlin$5,988,814
- Ralph Bernard Arlinghaus$3,580,180
- William K Plunkett$8,981,153
- Xifeng Wu$28,679,533
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionAdenosine TriphosphatePeptide Chemical SynthesisPharmacokineticsProtein SequenceProtein Tyrosine KinaseSynthetic PeptideChemical Registry /ResourceChemical Structure FunctionChimeric ProteinsChronic Myelogenous LeukemiaComputer SimulationCyclic PeptidesDifferential Display TechniqueAntileukemic AgentDrug ReceptorsEnzyme InhibitorsLactonesMultidrug ResistanceMolecular SiteNeoplasm /Cancer ChemotherapyYersinia PestisAntibacterial AgentsBinding Proteins
Grant awards (8)
Rapid Identification of Drug Targets in Yersinia pestis$228,849
R21 · FY2003 · EB
MOLECULAR MECHANISMS OF MULTI-DRUG RESISTANCE$233,489
R01 · FY2002 · GM
Rapid Identification of Drug Targets in Yersinia pestis$229,555
R21 · FY2002 · EB
PEPTIDOMIMETICS FOR INHIBITION OF P210BCRABL--CML$0
P01 · FY2002 · CA
MOLECULAR MECHANISMS OF MULTI-DRUG RESISTANCE$231,018
R01 · FY2001 · GM
PEPTIDOMIMETICS FOR INHIBITION OF P210BCRABL--CML$0
P01 · FY2001 · CA
MOLECULAR MECHANISMS OF MULTI-DRUG RESISTANCE$228,624
R01 · FY2000 · GM
PEPTIDOMIMETICS FOR INHIBITION OF P210BCRABL--CML$79,323
P01 · FY2000 · CA